Actualités id6383.html
In development: Guidance, quality standards and advice
Fri, 07 Feb 2025 03:54:00 GMT
Capivasertib with paclitaxel for untreated metastatic triple-negative breast cancer [ID6383] Technology appraisal guidance TBC Xevinapant with platinum-based chemotherapy and radiotherapy for ...